Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Multivit WS
- Development stage
- Unknown
- Lead developer
- Navana Pharmaceuticals
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Multivit WS is a probiotic-enriched veterinary feed supplement marketed by Navana Pharmaceuticals and manufactured by Polymix B.V.. It is formulated for poultry and contains a comprehensive blend of 4 probiotics (including Lactic acid Bacillus, Lactobacillus acidophilus, Bacillus subtilis, and Saccharomyces cerevisiae), 10 vitamins, 10 minerals, 4 amino acids, and antioxidants. Multivit WS is indicated for the prevention and treatment of vitamin deficiency syndromes, improving gut health and digestion, enhancing immunity, reducing mortality, and improving feed conversion ratio (FCR) in poultry.
- Brand names
- Multivit WS
- Other names
- Probiotics, Vitamins, Minerals, Amino acids, Antioxidants
Beyond the preview
Go deeper on Multivit WS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multivit WS.